Delivery Order SPE2DB20D3304-SPE2DB24FW6S9

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $5.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,024.29 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Micardis HCT 40-12.5 mg tablets in unit doses of 30s. This award is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which covers a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a $1,305.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Micardis HCT 80-25 mg tablets, with an ultimate completion date of September 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,818.62 to AmerisourceBergen Drug Corp for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $21,790.45 contract is for the provision of Micardis HCT 80-25 mg tablet units to support military treatment programs and facilities. The award is not set aside and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for Micardis HCT 80-25 MG Tablet UD 30S, a cardiovascular medication, with a ceiling value of $3,121.69 and a completion date of May 10, 2023. The contract is part of a broader Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA...
This is a $1,442.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, which are prescription cardiovascular medications. The contract has an ultimate completion date of December 21, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order for $1,093.20 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a prescription medication. The order is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,242.18, is for the supply of Micardis HCT 80-12.5 mg tablet medication. The contract is a firm-fixed price delivery order, with a period of performance through November 8, 2024. No set-aside designation was used for this award. In addition to this delivery order, AmerisourceBergen...
This is a $2,377.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication, in support of military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $6,528.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Micardis HCT 40-12.5 mg tablet units. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB24FW6S9
    Delivery Order

This is a $5,438.08 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Micardis HCT 80-25 mg tablet units, with a completion date of July 16, 2024. There was no set-aside designation used for this award.

The contract is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:00 AM